Patents Assigned to SpecNova LLC
  • Nutraceutical compositions
    Patent number: 11986457
    Abstract: The invention relates to nutraceutical compositions comprising dopamine transporter inhibitors and to their use as dietary supplements and food additives.
    Type: Grant
    Filed: March 16, 2022
    Date of Patent: May 21, 2024
    Assignee: SPECNOVA LLC
    Inventors: Sebastian Balcombe, William Hamilton, Jonathan Heal, Joseph Sheridan
  • Nutraceutical compositions
    Patent number: 11925615
    Abstract: The invention relates to nutraceutical compositions comprising dopamine transporter inhibitors and to their use as dietary supplements and food additives.
    Type: Grant
    Filed: March 16, 2022
    Date of Patent: March 12, 2024
    Assignee: SPECNOVA LLC
    Inventors: Sebastian Balcombe, William Hamilton, Jonathan Heal, Joseph Sheridan
  • NOVEL PROCESS
    Publication number: 20230398169
    Abstract: This invention relates to a process for preparing a tart cherry extract composition by combining a tart cherry extract with a rosmarinic acid extract. Related compositions and methods are also provided.
    Type: Application
    Filed: June 5, 2023
    Publication date: December 14, 2023
    Applicant: SpecNova LLC
    Inventor: Sebastian BALCOMBE
  • NOVEL PROCESS
    Publication number: 20230145702
    Abstract: The invention relates to a process for preparing an elderberry extract composition. The invention also relates to an elderberry extract composition obtainable by the aforementioned process and nutraceutical and pharmaceutical compositions comprising said extract composition.
    Type: Application
    Filed: October 17, 2022
    Publication date: May 11, 2023
    Applicant: SPECNOVA LLC
    Inventor: Sebastian BALCOMBE
  • NOVEL COMPOSITION
    Publication number: 20230089704
    Abstract: The invention provides a fenugreek extract composition containing at least one of diosgenin, gitogenin, sarsasapogenin, dioscin, protodioscin, pseudoprotodioscin, apigenin or a derivative thereof, luteolin or a derivative thereof, nicotinic acid or a derivative thereof, and kaempferol, or a salt or solvate of any one thereof. Also provided are processes of preparing the extract composition, and nutraceutical and pharmaceutical compositions containing the extract composition.
    Type: Application
    Filed: September 22, 2022
    Publication date: March 23, 2023
    Applicant: SpecNova LLC
    Inventor: Sebastian BALCOMBE
  • NOVEL COMPOSITION
    Publication number: 20220409635
    Abstract: Provided is a Withania somnifera extract composition contains at least one of withaferin A, withanoside IV, withanoside V, withanoside VI, withanolide A, withanolide B, anaferine, anahygrine, 12-deoxywithastromonolide, sitoindoside X, sitoindoside IX, cuscohygrine, isopelletierine, bracteosin A, bracteosin B, or bracteosin C, or a salt or solvate of any one thereof. Related compositions, methods, and processes are also provided.
    Type: Application
    Filed: June 21, 2022
    Publication date: December 29, 2022
    Applicant: SpecNova LLC
    Inventor: Sebastian BALCOMBE
  • NOVEL NUTRACEUTICAL COMPOSITIONS
    Publication number: 20220296562
    Abstract: The invention relates to nutraceutical compositions comprising dopamine transporter inhibitors and to their use as dietary supplements and food additives.
    Type: Application
    Filed: March 16, 2022
    Publication date: September 22, 2022
    Applicant: SpecNova LLC
    Inventors: Sebastian BALCOMBE, William HAMILTON, Jonathan HEAL, Joseph SHERIDAN
  • NOVEL PHARMACEUTICAL COMPOSITIONS
    Publication number: 20220296537
    Abstract: The invention relates to pharmaceutical compositions comprising dopamine transporter inhibitors and to their use in the prophylaxis or treatment of disease states or conditions mediated by the dopamine transporter.
    Type: Application
    Filed: March 16, 2022
    Publication date: September 22, 2022
    Applicant: SpecNova LLC
    Inventors: Sebastian BALCOMBE, William HAMILTON, Jonathan HEAL, Joseph SHERIDAN